孤独症谱系障碍负担现状分析及趋势预测

doi:10.11852/zgetbjzz2024-0006

中国儿童保健杂志 ›› 2024, Vol. 32 ›› Issue (12): 1349-1353.DOI: 10.11852/zgetbjzz2024-0006

孤独症谱系障碍负担现状分析及趋势预测

海洋¹, 金美钰¹, 张特², 崔禹¹, 武丽杰¹

1.哈尔滨医科大学公共卫生学院儿少卫生与妇幼保健学教研室,黑龙江哈尔滨 150081;
2.哈尔滨市第一专科医院精神科

收稿日期:2024-01-03 修回日期:2024-05-06 发布日期:2024-12-10 出版日期:2024-12-10
通讯作者: 武丽杰,E-mail: wulijiehyd@126.com
作者简介:海洋(1984-),男,副研究员,在读博士研究生,主要研究方向为儿童发育障碍及行为问题。

Prevalence analysis and trend prediction of the burden of autism spectrum disorder

HAI Yang¹, JIN Meiyu¹, ZHANG Te², CUI Yu¹, WU Lijie¹

1. Department of Children's and Adolescent Health, Public Health College, Harbin Medical University, Harbin, Heilongjiang 150081, China;
2. Department of Psychiatry,the First Psychiatric Hospital of Harbin

Received:2024-01-03 Revised:2024-05-06 Online:2024-12-10 Published:2024-12-10
Contact: WU Lijie, E-mail: wulijiehyd@126.com

摘要/Abstract

摘要： 目的通过对全球疾病负担(GBD)数据库的分析,了解中国与全球孤独症谱系障碍(ASD)的疾病负担现状及流行特征,并对2030年疾病负担进行预测,为预防和控制因ASD导致的疾病负担提供参考依据。方法收集全球疾病负担数据库中1990—2019中国及全球ASD患病及伤残调整生命年(DALYs)数据,运用Joinpoint回归模型分析ASD疾病负担随时间的变化并计算平均年度变化百分比(AAPC),构建自回归移动平均模型(ARIMA)预测2020—2030年中国与全球ASD疾病负担趋势。结果中国1990—2019年中国年龄标化患病率和年龄标化DALYs率均呈上升趋势,平均每年分别上升0.14%和0.15%,且上升幅度高于全球平均水平(AAPC=-0.03%,P<0.001,AAPC=-0.03%,P<0.001)。预测至2030年中国ASD年龄标化患病率和年龄标化DALYs率均呈上升趋势,分别为376.08/10⁵和57.90/10⁵,相比全球ASD年龄标化患病率和年龄标化DALYs率分别为369.47/10⁵和56.28/10⁵,呈较平稳趋势。中国及全球5岁以下年龄组的男童ASD疾病负担最大。结论中国ASD疾病负担在过去三十年持续上升,并且在未来可能超过全球平均水平,实施有针对性的应对措施显得尤为紧迫。

关键词: 孤独症谱系障碍, 全球疾病负担, 伤残调整生命年, Joinpoint回归模型, 自回归移动平均模型

Abstract: Objective To compare and analyze the current burden status of autism spectrum disorders (ASD) in China and globally, to extract the epidemiological characteristics and to predict the burden in 2030, based on the analysis of the global burden of disease (GBD) database, so as to provide reference for the prevention and control of the disease burden caused by ASD. Methods Prevalence and disability-adjusted life years (DALYs) data from 1990 to 2019 for ASD in China and globally were retrieved from the GBD database. Joinpoint regression model was used to analyze the changes in ASD disease burden and calculate average annual percentage change (AAPC) over time. Auto regressive integrated moving average model(ARIMA) was constructed to predict the trend of ASD disease burden in China and globally from 2020 to 2030. Results The age standardized prevalence rate and age standardized DALYs rate in China showed an upward trend from 1990 to 2019, with an average annual increase of 0.14% and 0.15%, respectively, and the increase was higher than the global average level (AAPC=-0.03%, P<0.001, AAPC=-0.03%, P<0.001). It is predicted that the age standardized prevalence rate and age standardized DALYs rate of ASD in China will both show an upward trend by 2030, reaching 376.08/10⁵ and 57.90/10⁵, respectively. In comparison, the global age standardized prevalence rate and age standardized DALYs rate of ASD, which are 369.47/10⁵ and 56.28/10⁵, respectively, and the trend is relatively stable. The burden of ASD is biggest for male children under the age of 5 in China and globally. Conclusion Over the past three decades, the burden of ASD in China has persistently escalated and may exceed the global average in the future, making it particularly urgent to implement targeted prevention and control measures.

Key words: autism spectrum disorder, global burden of disease, disability-adjusted life years, Joinpoint regression model, auto regressive integrated moving average model

中图分类号:

R749.94

海洋, 金美钰, 张特, 崔禹, 武丽杰. 孤独症谱系障碍负担现状分析及趋势预测[J]. 中国儿童保健杂志, 2024, 32(12): 1349-1353.

HAI Yang, JIN Meiyu, ZHANG Te, CUI Yu, WU Lijie. Prevalence analysis and trend prediction of the burden of autism spectrum disorder[J]. Chinese Journal of Child Health Care, 2024, 32(12): 1349-1353.

参考文献

[1] American Psychiatric Association. Diagnostic and statistical manual of mental disorders [M]. 5th ed. Washington: American Psychiatric Publishing, 2013.
[2] Zeidan J, Fombonne E, Scorah J, et al. Global prevalence of autism: A systematic review update[J]. Autism Res, 2022, 15(5): 778-790.
[3] Centers for Disease Control and Prevention. Data & statistics on autism spectrum disorder[R/OL]. 2023-4-4. https://www.cdc.gov/ncbddd/autism/data.html
[4] Salari N, Rasoulpoor S, Rasoulpoor S, et al. The global prevalence of autism spectrum disorder:A comprehensive systematic review and meta-analysis[J]. Ital J Pediatr, 2022, 48(1): 1-16.
[5] Zhou H, Xu X, Yan W, et al. Prevalence of autism spectrum disorder in China: A nationwide multi-center population-based study among children aged 6 to 12 years[J]. Neurosci Bull, 2020(36): 961-971.
[6] Cakir J, Frye RE, Walker SJ. The lifetime social cost of autism: 1990—2029[J]. Res Autism Spectr Disord, 2020(72): 101502,
[7] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990—2019: A systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258):1204-1222.
[8] Benmei L, Hyune JK, Eric JF, et al. Joinpoint regression methods of aggregate outcomes for complex survey data[J]. J Surv Stat Methodol, 2023, 11(4): 967-989.
[9] Yoneoka D, Nomura S, Tanaka S, et al. Prediction of disability-adjusted life years for diseases due to low fruit intake in 2017—2040 in Japan[J]. Public Health Nutr, 2021, 24(10): 3156-3166.
[10] World Health Organization.Mental health atlas 2020[R/OL].2021-10-8.https://www.who.int/publications/i/item/9789240036703.
[11] 徐杰茹,陈磊,王冕,等.1990—2019年中国女性卵巢癌发病趋势分析与预测[J].现代预防医学, 2021,48(19):3457-3460.
Xu JR, Chen L, Wang M, et al. Analysis and forecast of the incidence trend of ovarian cancer in Chinese women 1990—2019[J]. Modern Preventive Medicine, 2021, 48(19):3457-3460. (in Chinese)
[12] GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990—2019:A systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Psychiatry, 2022, 9(2): 137-150.

[1]	李廷玉, 韦秋宏, 李燕, 魏华, 代英, 陈立. 养育照护融合家庭干预模式用于孤独症谱系障碍的实践与展望[J]. 中国儿童保健杂志, 2024, 32(9): 937-940.
[2]	静进. 孤独症谱系障碍“神经多样性”的观点及其评价[J]. 中国儿童保健杂志, 2024, 32(7): 709-712.
[3]	丛妍, 王浩, 王栋, 俞露婷, 朱晓春. 婴儿期运动发育指标在孤独症谱系障碍儿童筛查中的应用[J]. 中国儿童保健杂志, 2024, 32(7): 752-756.
[4]	张蓓, 王敏囡, 尼罗帕, 古丽加娜提·阿布拉克木, 克日曼·帕尔哈提, 何艳红, 阿曼古丽·卡德尔, 热娜·买买提. 产后早期免疫激活对小鼠孤独症样行为和胶质细胞的影响[J]. 中国儿童保健杂志, 2024, 32(4): 405-411.
[5]	杨峰. 从言语病理学角度看孤独症谱系障碍儿童的沟通障碍[J]. 中国儿童保健杂志, 2024, 32(3): 233-236.
[6]	王峰, 刘泽慧, 张艺霖, 田文茹, 杨凌渊, 邹明扬, 孙彩虹. 孤独症谱系障碍儿童外周血CNR1基因甲基化修饰水平的研究[J]. 中国儿童保健杂志, 2024, 32(3): 237-241.
[7]	侯耀奇, 宋湘勤. 运动干预改善孤独症谱系障碍儿童社会功能的研究进展[J]. 中国儿童保健杂志, 2024, 32(3): 291-295.
[8]	邹红, 朱健芳, 罗佳怡, 李丹丹, 吴迪. 孤独症谱系障碍的干预方法及发展趋势[J]. 中国儿童保健杂志, 2024, 32(3): 317-321.
[9]	蔚然, 孔锐, 关陆阳, 王永露, 叶侃. 益生菌对孤独谱系障碍患者核心症状干预效果的荟萃分析[J]. 中国儿童保健杂志, 2024, 32(3): 322-328.
[10]	胥柯, 周勤, 吴明磊, 宋丽, 柯晓燕. 孤独症谱系障碍儿童的饮食睡眠问题及相关因素[J]. 中国儿童保健杂志, 2024, 32(3): 329-333.
[11]	肖乐, 叶小姗. 重视孤独症谱系障碍发生的神经生物学机制[J]. 中国儿童保健杂志, 2024, 32(12): 1277-1281.
[12]	黄天然, 刘姝娆, 张艳婷, 岑丽婷, 陆燕珍. 血清25-(OH)D和维生素B12水平与孤独症谱系障碍儿童病情特征的相关性[J]. 中国儿童保健杂志, 2024, 32(12): 1384-1388.
[13]	干凯滟, 黄安琪, 张子一, 关陆阳, 王菲, 柯晓燕. M-CHAT筛查阳性对孤独症谱系障碍早期诊断稳定性的前瞻性研究[J]. 中国儿童保健杂志, 2024, 32(10): 1076-1079.
[14]	杨帆, 李庆红, 李翌鸣, 杨顺波, 李威, 吕智海. 孤独症谱系障碍儿童屏幕使用现状及其与核心症状的相关性[J]. 中国儿童保健杂志, 2024, 32(10): 1080-1084.
[15]	静进. 孤独症谱系障碍的治疗干预现状与建议[J]. 中国儿童保健杂志, 2023, 31(9): 939-944.

孤独症谱系障碍负担现状分析及趋势预测

Prevalence analysis and trend prediction of the burden of autism spectrum disorder

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics